FPC
GILD icon

Falcon Point Capital’s Gilead Sciences GILD Stock Holding History

Falcon Point Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-2,604
Closed -$245K – 120
2014
Q4 		$245K Sell
2,604
-6,219
-70% -$643K 0.22% 102
2014
Q3 		$939K Sell
8,823
-6,890
-44% -$675K 0.79% 47
2014
Q2 		$1.3M Sell
15,713
-1,653
-10% -$129K 1.31% 25
2014
Q1 		$1.23M Buy
17,366
+233
+1% +$18.3K 1.18% 26
2013
Q4 		$1.29M Buy
17,133
+558
+3% +$38.9K 1.23% 19
2013
Q3 		$1.04M Sell
16,575
-450
-3% -$26.9K 1.11% 24
2013
Q2 		$873K Buy
+17,025
New +$887K 0.96% 35

Other funds holding GILD

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Falcon Point Capital's GILD Position: Q1 2015 in Review

Falcon Point Capital sold out of Gilead Sciences (GILD) in Q1 2015, closing a stake of 2,604 shares — an estimated $245K sold.

Falcon Point Capital first reported a position in GILD in Q2 2013 and held it in 7 quarters. The position peaked at $1.3M in Q2 2014. 1,492 funds tracked by Wall St. Rank hold GILD as of Q1 2015.

  • Falcon Point Capital reported no remaining Gilead Sciences position as of Q1 2015 after selling out during the quarter.
  • Falcon Point Capital sold 2,604 Gilead Sciences shares in Q1 2015, an estimated $245K.
  • Falcon Point Capital first reported a position in Gilead Sciences in Q2 2013 and held it in 7 quarters.
  • Falcon Point Capital's Gilead Sciences position peaked at $1.3M in Q2 2014.
  • 1,492 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2015.

Based on Falcon Point Capital's 13F filing for Q1 2015, filed 13 Apr 2015.